Viewing data from:

DAYSEE

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A091467 | LUPIN LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: QUARTETTE(TE code: AB)

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. et al 3:2010cv00603 1 patentANDA 091467ethinyl estradiol and levonorgestrel	D.N.J.	2010-02-03	Terminated 2012-06-29	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Medicare Part D Spending

CMS annual spending data for Daysee (2023)

Total Spending

$137K

Total Claims

1,857

Beneficiaries

753

Avg Cost/Unit

$0.81

Spending Trend

$180K(2019)→$146K(2020)→$87K(2021)→$106K(2022)→$137K(2023)

YoY Change:-5.9%

5yr CAGR:-13.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG,0.01MG;0.15MG,N/A

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 10, 2013

No patent or exclusivity listings for this strength.